The Valley Desk

NCT00013806 · Interventional trial

CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study

Overall registry status Unknown

Phase 2

Conditions Neuroblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov